$Serve Robotics (SERV.US)$ wonder who’s holding at above $18 ?

$Tonix Pharmaceuticals (TNXP.US)$
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at 7th International Congress on Controversies in Fibromyalgia
Tuesday, 4th March at 7:00 am
TNX-102 SL is a sublingual formulation of cyclobenzaprine designed for transmucosal delivery and durable activity in treating fibromyalgia
TNX-102 SL demonstrated statistically significant improvement in the primary endpoint of reduction in fibromyalgia pain in two doub...

$GENM (4715.MY)$ buy buy buy! push it up and let the margin shorter players lose!

$MRCB (1651.MY)$ GROK3 conducts further precise analysis and forecasting of MRCB (Malaysian Resources Corporation Berhad) revenue and profit in Q4 2024.
Since MRCB has not yet released the official financial report for Q4 2024 as of February 20, 2025, optimization of the forecast will be performed through the following steps:
1 Integrate the latest available data (Q3 2024 and earlier).
2 Analyze project progress, revenue recognition model, and cost factors.
3 Refine assumptions based on Industry trends and MRCB's historical performance.
4 Provide a narrower forecast range and the most likely value.
Data foundation and updates.
1. Actual data for Q3 2024.
• Revenue: 0.42634 billion Ringgit (MarketScreener, November 28, 2024).
• Net income: 8.86 million Ringgit (down 82.69% year-on-year, compared to 51.18 million Ringgit in the same period last year).
• Reason: Decline in revenue from the ECE department (completion of LRT3), delay in real estate sales.
2. Cumulative for January to September 2024 (9M 2024)
• Revenue: Approximately 1.399 billion Ringgit...

$Tonix Pharmaceuticals (TNXP.US)$ lets go!  Up again

$Tonix Pharmaceuticals (TNXP.US)$
On February 20, 2025, Tonix Pharmaceuticals received confirmation from NASDAQ that it has regained compliance with the minimum bid price requirement for continued listing on the NASDAQ Capital Market. The company's shares maintained a closing bid price at or above $1.00 per share for at least 10 consecutive business days, satisfying NASDAQ Listing Rule 5550(a)(2).

$Serve Robotics (SERV.US)$ Already rebounded.